Clinical trial
Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
NCT01159639 is registered in ClinicalTrials.gov with University of Zagreb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
- Lead sponsor
- University of Zagreb
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- February 28, 2013
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aspirin resistance, coronary artery disease